Free Trial
NASDAQ:TLSI

TriSalus Life Sciences (TLSI) Stock Price, News & Analysis

TriSalus Life Sciences logo
$4.95 -0.06 (-1.12%)
As of 01:03 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About TriSalus Life Sciences Stock (NASDAQ:TLSI)

Key Stats

Today's Range
$4.85
$5.08
50-Day Range
$4.90
$5.59
52-Week Range
$3.50
$6.04
Volume
19,263 shs
Average Volume
51,758 shs
Market Capitalization
$187.46 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.75
Consensus Rating
Buy

Company Overview

TriSalus Life Sciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
53rd Percentile Overall Score

TLSI MarketRank™: 

TriSalus Life Sciences scored higher than 53% of companies evaluated by MarketBeat, and ranked 507th out of 920 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    TriSalus Life Sciences has received a consensus rating of Buy. The company's average rating score is 3.25, and is based on 6 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    TriSalus Life Sciences has received no research coverage in the past 90 days.

  • Read more about TriSalus Life Sciences' stock forecast and price target.
  • Earnings Growth

    Earnings for TriSalus Life Sciences are expected to grow in the coming year, from ($1.55) to ($0.61) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of TriSalus Life Sciences is -4.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of TriSalus Life Sciences is -4.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about TriSalus Life Sciences' valuation and earnings.
  • Percentage of Shares Shorted

    0.75% of the float of TriSalus Life Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    TriSalus Life Sciences has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in TriSalus Life Sciences has recently increased by 266.06%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    TriSalus Life Sciences does not currently pay a dividend.

  • Dividend Growth

    TriSalus Life Sciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.75% of the float of TriSalus Life Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    TriSalus Life Sciences has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in TriSalus Life Sciences has recently increased by 266.06%, indicating that investor sentiment is decreasing significantly.
  • Search Interest

    1 people have searched for TLSI on MarketBeat in the last 30 days.
  • MarketBeat Follows

    Only 1 people have added TriSalus Life Sciences to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, TriSalus Life Sciences insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $83,528.00 in company stock.

  • Percentage Held by Insiders

    27.50% of the stock of TriSalus Life Sciences is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 2.58% of the stock of TriSalus Life Sciences is held by institutions.

  • Read more about TriSalus Life Sciences' insider trading history.
Receive TLSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TriSalus Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

TLSI Stock News Headlines

Why Volatility Keeps Coming Back — And How I Trade It
Volatility isn’t the enemy — it’s the opportunity. While most traders panic during market swings, Jeff Clark uses a three-step method to target quick wins from VIX spikes and sudden price moves. It works in any market direction… and he’s showing how it works in a free video, available now.
See More Headlines

TLSI Stock Analysis - Frequently Asked Questions

TriSalus Life Sciences' stock was trading at $5.01 at the beginning of the year. Since then, TLSI shares have decreased by 1.1% and is now trading at $4.9540.

TriSalus Life Sciences, Inc. (NASDAQ:TLSI) released its quarterly earnings data on Thursday, May, 15th. The company reported ($0.33) EPS for the quarter, missing analysts' consensus estimates of ($0.20) by $0.13. The company had revenue of $9.17 million for the quarter, compared to the consensus estimate of $9.04 million.
Read the conference call transcript
.

Shares of TLSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that TriSalus Life Sciences investors own include AutoZone (AZO), Intel (INTC), Meta Platforms (META), Merck & Co., Inc. (MRK), TJX Companies (TJX), Abacus Health Products (ABAHF) and Airbnb (ABNB).

Company Calendar

Last Earnings
5/15/2025
Today
7/10/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:TLSI
Previous Symbol
NASDAQ:TLSI
CIK
1826667
Fax
N/A
Employees
106
Year Founded
N/A

Price Target and Rating

High Price Target
$12.50
Low Price Target
$10.00
Potential Upside/Downside
+114.6%
Consensus Rating
Buy
Rating Score (0-4)
3.25
Research Coverage
8 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$30.05 million
Pretax Margin
-84.65%

Debt

Sales & Book Value

Annual Sales
$29.43 million
Price / Cash Flow
N/A
Book Value
($0.83) per share
Price / Book
-6.04

Miscellaneous

Free Float
27,433,000
Market Cap
$189.58 million
Optionable
Not Optionable
Beta
0.50
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:TLSI) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners